Perrigo wins FDA nod to market generic children's allergy syrup

09/10/2013 | Drug Store News

The FDA gave Perrigo its final approval on Tuesday to market the store-brand equivalent to Children's Zyrtec Allergy Syrup, an indoor/outdoor allergy drug for children aged 2 years and older. The company expects to start shipments of this generic version during the upcoming cough/cold/flu season.

View Full Article in:

Drug Store News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA